NVO

Novo Nordisk
$49.67
+$0.90 (+1.85%)Jul 27, 2026
9.3GreatMoatMint rating

MoatMint rates Novo Nordisk (NVO) 9.3 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 9.4 out of 10.

Key metrics

The numbers that frame NVO today
Market cap
$221.78B
P/E (TTM)
11.6
EV / FCF
25.4
Gross margin
81.8%
EV / Sales
4.7
ROIC
55.6%
Div yield
3.74%
Debt / equity
0.7
52wk Low
$34.60
52wk High
$68.55

NVO stock rating

How NVO scores on quality, value, growth, momentum and financial health
9.3out of 10
Great overallHealthy business, attractive priceTop 7% of ~5,000 US stocks
QualityGreat9.4/10
GrowthGreat8.7/10
MomentumFair3.6/10
ValueGreat8.3/10
Financial HealthGreat9.2/10

Growth

Revenue and earnings trend for NVO
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about NVO
Is Novo Nordisk a good buy?
Yes. Novo Nordisk has excellent quality, and it outweighs the weak momentum here. Growth looks excellent, which supports the long-term business case. We think Novo Nordisk is selling at a low price.
What is the market capitalization of NVO?
Novo Nordisk's market capitalization is $221.78B.
What is the P/E ratio for NVO stock?
Novo Nordisk's current P/E ratio is 11.6.
What is the 52-week high for NVO stock?
The 52-week high for Novo Nordisk is $68.55. The current close of $49.67 is 27.5% below that high.
What is the 52-week low for NVO stock?
The 52-week low for Novo Nordisk is $34.60. The current close of $49.67 is 43.6% above that low.
Does NVO stock pay dividends?
Novo Nordisk pays a dividend. The latest dividend per share in the company data is $1.86, which implies a yield of 3.74% based on the current close.
What is the Debt / Equity ratio for NVO?
Novo Nordisk's Debt / Equity ratio is 0.72.